# Cilostazol vs. Aspirin in Acute Non-cardioembolic Stroke With Cerebral mIcrobleeds

Study · id `cardio:ct-nct06530537` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06530537](<https://clinicaltrials.gov/study/NCT06530537>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06530537

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 848 participants.

## Technical summary

Registry record NCT06530537. Randomized; no masking; primary purpose treatment. Start 2024-07-18 (actual); primary completion 2031-08-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 848 participants (planned count; ClinicalTrials.gov record NCT06530537, source copy `cardio:ctgov-nct06530537-2024-07-31`, retrieved 2026-10-26)
- Started: 2024-07-18 (actual) (ClinicalTrials.gov record NCT06530537, source copy `cardio:ctgov-nct06530537-2024-07-31`, retrieved 2026-10-26)
- Primary completion: 2031-08-30 (anticipated) (ClinicalTrials.gov record NCT06530537, source copy `cardio:ctgov-nct06530537-2024-07-31`, retrieved 2026-10-26)
- Completion: 2031-08-30 (anticipated) (ClinicalTrials.gov record NCT06530537, source copy `cardio:ctgov-nct06530537-2024-07-31`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06530537, source copy `cardio:ctgov-nct06530537-2024-07-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06530537-2024-07-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: Cilostazol vs. Aspirin in Acute Non-cardioembolic Stroke With Cerebral mIcrobleeds
- Condition: Cerebral Microbleeds
- Condition: Stroke
- Intervention (Drug): Cilostazol
- Intervention (Drug): Aspirin
- Lead sponsor: Zhejiang Provincial People's Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry lists this organization as the lead sponsor: Zhejiang Provincial People's Hospital (`cardio:org-zhejiang-provincial-people-s-hospital`)

## Provenance

Content hash: 24264dd42a9f27b86a790e4fb709d3fed22a3f7cb25dc38c91d45976716cef54
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
